Taro Pharmaceutical Industries Ltd. logo
Taro Pharmaceutical Industries Ltd. TARO
$ 42.97 0.0%

Annual report 2022
added 07-25-2022

report update icon

Taro Pharmaceutical Industries Ltd. Income Statement 2011-2024 | TARO

Annual Income Statement Taro Pharmaceutical Industries Ltd.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.36 B 1.83 B 2.73 B 4.19 B 3.58 B 4.21 B 5.23 B 5.26 B 4.35 B 2.36 B 1.72 B 1.23 B

Shares

37.6 M 38.2 M 38.5 M 39 M 40.2 M 41.3 M 42.8 M 42.8 M 44.3 M 44.7 M 44.6 M 44.5 M

Historical Prices

36 48.9 71.5 67.3 89.4 85.7 105 127 132 97.5 49.8 33.2

Net Income

58.3 M -387 M 244 M 282 M 211 M 456 M 541 M 484 M 360 M 266 M 47.3 M 183 M

Revenue

561 M 549 M 645 M 670 M 662 M 879 M 951 M 863 M 759 M 671 M 145 M 506 M

Cost of Revenue

268 M 252 M 245 M 224 M 198 M 208 M 170 M 186 M 179 M 176 M - 176 M

Gross Profit

293 M 297 M 400 M 446 M 464 M 672 M 781 M 677 M 580 M 495 M 99.2 M 330 M

Operating Income

63.5 M -414 M 247 M 296 M 303 M 515 M 614 M 528 M 430 M 329 M - 204 M

Interest Expense

- - - - - - - - - - - 609 K

EBITDA

89.4 M -390 M 268 M 315 M 320 M 530 M 629 M 543 M 447 M 346 M 70.8 M 223 M

Operating Expenses

230 M 710 M 153 M 150 M 160 M 156 M 164 M 149 M 150 M 166 M 128 M 125 M

General and Administrative Expenses

57.1 M 52.8 M 56.8 M 90 M 88.2 M 85.7 M 92.4 M 87.6 M 91.7 M 86.4 M 23.1 M 93.9 M

All numbers in USD currency

Quarterly Income Statement Taro Pharmaceutical Industries Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - - 37.9 M - - - 38.3 M - - - 38.5 M - - - 39.4 M - - - 40.5 M - - - 42.8 M - - - 42.8 M - - - 42.8 M - - - 44.8 M - - - 44.5 M 44.5 M - - 44.3 M

Net Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 47.3 M - - - 25.7 M

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 145 M - - - 108 M

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 46 M - - - 44.6 M

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 99.2 M - - - 63.1 M

Operating Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 66.2 M - - - 33.4 M

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -94 K - - - 251 K

EBITDA

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 70.8 M - - - 38.1 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 32.9 M - - - 29.7 M

General and Administrative Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 8.74 M - - - 22.5 M

All numbers in USD currency